找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: New Antimicrobials: For the Present and the Future; I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l

[復(fù)制鏈接]
查看: 8585|回復(fù): 52
樓主
發(fā)表于 2025-3-21 19:45:29 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future
編輯I.W. Fong
視頻videohttp://file.papertrans.cn/665/664778/664778.mp4
概述Summarizes the last decade of advances in antibiotics, antivirals, antifungals, and antiparasitic agents.Details pharmacology, chemical nature, antimicrobial spectrum, dosage, efficacy, and more for e
叢書(shū)名稱(chēng)Emerging Infectious Diseases of the 21st Century
圖書(shū)封面Titlebook: New Antimicrobials: For the Present and the Future;  I.W. Fong Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l
描述This is a timely and essential companion to the recently published .Antimicrobial Resistance in the 21st Century, Second Edition. .Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO‘s top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade.?.Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis
出版日期Book 2023
關(guān)鍵詞antimicrobial resistance; antimicrobial agents; antibiotic; antifungal; antiparasitic; systemic infection
版次1
doihttps://doi.org/10.1007/978-3-031-26078-0
isbn_softcover978-3-031-26080-3
isbn_ebook978-3-031-26078-0Series ISSN 1573-4684 Series E-ISSN 2627-5872
issn_series 1573-4684
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future影響因子(影響力)




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future被引頻次




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future被引頻次學(xué)科排名




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future年度引用




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future年度引用學(xué)科排名




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future讀者反饋




書(shū)目名稱(chēng)New Antimicrobials: For the Present and the Future讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:17:59 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:05:09 | 只看該作者
I. W. Fonger Querschnittsschwerpunkte ersetzt. .? Es wird vorausgesetzt, dass alle Einwirkungen zeitlich unver?nderlich sind, so dass keine dynamischen Effekte auftreten. .? Bei der Formulierung des Gleichgewichts werden die Tragwerksverformungen als vernachl?ssigbar klein angenommen, d. h. es wird nach der T
地板
發(fā)表于 2025-3-22 06:32:10 | 只看該作者
Antimicrobial Resistance: A Crisis in the Making,sistant .) and malaria (artemisinin-resistant .), certain viral infections (cytomegalovirus and human immunodeficiency virus), and specific fungal opportunistic pathogens (. and . sp.)..It is estimated that 700,000 deaths occur yearly in the world from AMR infections and projected to escalate to ten
5#
發(fā)表于 2025-3-22 12:19:24 | 只看該作者
New Glycopeptides: Telavancin, Dalbavancin, and Oritavancines to meet the unmet needs. These new agents, telavancin, dalbavancin, and oritavancin, are more potent and have superior pharmacokinetic profile than the first-generation glycopeptides (vancomycin and teicoplanin). This chapter discusses these new semisynthetic agents’ in vitro activity, pharmacolo
6#
發(fā)表于 2025-3-22 16:25:48 | 只看該作者
New Tetracyclines: Eravacycline and Omadacyclinea-abdominal infections and omadacycline for community-acquired pneumonia and acute bacterial skin and soft tissue infections. This chapter reviews their chemical structure, pharmacokinetic and pharmacodynamics parameters, microbial activity, ease of resistance, clinical efficacy, adverse effects, an
7#
發(fā)表于 2025-3-22 17:25:50 | 只看該作者
8#
發(fā)表于 2025-3-22 23:15:57 | 只看該作者
New Antiviral Agent for Influenza: Baloxaviroral antiviral, baloxavir, was approved in the United States for influenza infection. This chapter reviews the chemistry, antiviral activity, pharmacokinetics, efficacy, and side effects of baloxavir.
9#
發(fā)表于 2025-3-23 04:30:55 | 只看該作者
Book 2023for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparis
10#
發(fā)表于 2025-3-23 09:28:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 06:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
桐城市| 杂多县| 瑞昌市| 长岛县| 辉南县| 泰和县| 贵阳市| 乡城县| 海城市| 丹阳市| 淄博市| 夏邑县| 封开县| 芦山县| 堆龙德庆县| 临邑县| 许昌市| 柘荣县| 张家口市| 墨江| 安仁县| 延津县| 锡林郭勒盟| 泽库县| 湘潭县| 沈阳市| 株洲县| 柞水县| 南城县| 张家口市| 肥城市| 南宫市| 衡山县| 和田县| 罗田县| 东山县| 罗平县| 通江县| 天峻县| 恭城| 大城县|